Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Extrapulmonary, draining lesions (including scrofula) |
Discontinue isolation only when patient is improving clinically, and drainage has ceased or there are three consecutive negative cultures of continued drainage. Examine for evidence of active pulmonary tuberculosis. |
||
Extrapulmonary, meningitis |
*Patient should be examined for evidence of current (active) pulmonary tuberculosis. If evidence exists, additional isolations are necessary |
||
Skin-test (PPD) or interferon gamma release assay (e.g., QuaniFEron) positive with no evidence of active pulmonary disease | |||
Pulmonary (suspected or confirmed) OR laryngeal disease |
AFB smear positive: |
Collect 3 separate AFB sputum obtained at 8-12 hr intervals (at least 1 specimen must be in early AM). See Discuss with HEIP before discontinuing airborne isolation AFB smear-positive: AFB smear-negative: High risk for MDR TB and either AFB smear-negative or smear-positive: |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Draining lesion |
Provided draining lesions can be adequately covered/contained |
||
Pulmonary |
Provided draining lesions can be adequately covered/contained |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
|
See gastroenteritis |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
endemic and epidemic (Rickettsia sp.) |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
When clinical syndrome suspected and/or no organism identified on further testing |
duration of illness or until specific pathogen is known |
Initiate isolation when test is ordered to rule out viral pathogens. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Vaccinia Vaccination site care (including autoinoculated areas) |
Only vaccinated HCPs may have contact with active vaccination sites and care for persons with adverse vaccinia events; if unvaccinated, only HCPs without contraindications to vaccine may provide care. Vaccination recommended for vaccinators; for newly vaccinated HCWs: semi-permeable dressing over gauze until scab separates, with dressing change as fluid accumulates, ~3-5 days; gloves, hand hygiene for dressing change; vaccinated HCW or HCW without contraindication to vaccine for dressing changes. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Eczema vaccinatum |
Until lesions dry and crusted, scabs separated |
For Contact + Standard with virus-containing lesions and exudative material. |
|
Fetal vaccinia |
Until lesions dry and crusted, scabs separated |
For Contact + Standard with virus-containing lesions and exudative material. |
|
Generalized vaccinia |
Until lesions dry and crusted, scabs separated |
For Contact + Standard with virus-containing lesions and exudative material. |
|
Progressive vaccinia |
Until lesions dry and crusted, scabs separated |
For Contact + Standard with virus-containing lesions and exudative material. |
|
Postvaccinia encephalitis |
Until lesions dry and crusted, scabs separated |
||
Blepharitis or conjunctivitis |
Use Contact + Standard Precautions if there is copious drainage. |
||
Iritis or keratitis | |||
Vaccinia-associated erythema multiforme (Stevens Johnson Syndrome) |
Not an infectious condition |
||
Secondary bacterial infection (e.g., S. aureus, group A beta hemolytic Streptococcus) |
Follow organism-specific (strep, staph most frequent) recommendations and consider magnitude of drainage. |